gyki 52466 has been researched along with Paralysis in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brison, E | 1 |
| Jacomy, H | 1 |
| Desforges, M | 1 |
| Talbot, PJ | 1 |
1 other study available for gyki 52466 and Paralysis
| Article | Year |
|---|---|
Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.
Topics: Animals; Benzodiazepines; Blotting, Western; Coronavirus Infections; Coronavirus OC43, Human; Excita | 2011 |